Evidence map›Paper›PMID 37002899›Full record

ArticleDevelopmental dynamics : an official publication of the American Association of Anatomists2023

Identification of unique α4 chain structure and conserved antiangiogenic activity of α3NC1 type IV collagen in zebrafish.

Valerie S LeBleu, Jianli Dai, Susan Tsutakawa, Brian A MacDonald, Joseph L Alge, Malin Sund, Liang Xie, Hikaru Sugimoto, John Tainer, Leonard I Zon and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Developmental dynamics : an official publication of the American Association of Anatomists, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Valerie S LeBleuDepartment of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID 0000-0002-8514-8551
Jianli DaiDepartment of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Susan TsutakawaLawrence Berkeley National Laboratory, University of California, Berkeley, California, USA.
Brian A MacDonaldDivision of Matrix Biology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Joseph L AlgeDepartment of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Malin SundDivision of Matrix Biology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Liang XieDivision of Matrix Biology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Hikaru SugimotoDepartment of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
John TainerDepartment of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Leonard I ZonDepartment of Hematology/Oncology, Children's Hospital, Boston, Massachusetts, USA.
Raghu KalluriDepartment of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Beth Israel Deaconess Medical Center · USThe University of Texas MD Anderson Cancer Center · USBoston Children's Hospital · USLawrence Berkeley National Laboratory · USNorthwestern University · US

Funding

TYPE IV COLLAGEN IN ALPORT SYNDROME PATHOGENESISR01DK055001 · NIDDK · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KALLURI, RAGHU · 1999 to 2014
$4.3M
NIDDK NIH HHS R01 DK055001
6 · The paper itself

Abstract

backgroundType IV collagen is an abundant component of basement membranes in all multicellular species and is essential for the extracellular scaffold supporting tissue architecture and function. Lower organisms typically have two type IV collagen genes, encoding α1 and α2 chains, in contrast with the six genes in humans, encoding α1-α6 chains. The α chains assemble into trimeric protomers, the building blocks of the type IV collagen network. The detailed evolutionary conservation of type IV collagen network remains to be studied.

resultsWe report on the molecular evolution of type IV collagen genes. The zebrafish α4 non-collagenous (NC1) domain, in contrast with its human ortholog, contains an additional cysteine residue and lacks the M93 and K211 residues involved in sulfilimine bond formation between adjacent protomers. This may alter α4 chain interactions with other α chains, as supported by temporal and anatomic expression patterns of collagen IV chains during the zebrafish development. Despite the divergence between zebrafish and human α3 NC1 domain (endogenous angiogenesis inhibitor, Tumstatin), the zebrafish α3 NC1 domain exhibits conserved antiangiogenic activity in human endothelial cells.

conclusionsOur work supports type IV collagen is largely conserved between zebrafish and humans, with a possible difference involving the α4 chain.

Indexed as

Collagen Type IVZebrafishAnimalsBasement MembraneEndothelial CellsHumansProtein SubunitsCollagen Type IVProtein Subunitsangiogenesisbasement membranecollagen IVTumstatinzebrafish

Identifiers

PMID37002899
PMCPMC10524752
OpenAlexW4362453036

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.